Enhanced Performance Electrochemical Biosensor for Detection of Prostate Cancer Biomarker PCA3 Using Specific Aptamer

In the quest for the development of accurate, reliable, and cost-effective biosensing technology for early diagnostics of prostate cancer, we describe here an electrochemical biosensor combining a simple transducing method of differential pulse voltammetry (DPV) with an RNA-based aptamer labelled wi...

Full description

Bibliographic Details
Main Authors: Sarra Takita, Alexei Nabok, Anna Lishchuk, Magdi H. Mussa, David Smith
Format: Article
Language:English
Published: MDPI AG 2023-01-01
Series:Eng
Subjects:
Online Access:https://www.mdpi.com/2673-4117/4/1/22
_version_ 1797612022395830272
author Sarra Takita
Alexei Nabok
Anna Lishchuk
Magdi H. Mussa
David Smith
author_facet Sarra Takita
Alexei Nabok
Anna Lishchuk
Magdi H. Mussa
David Smith
author_sort Sarra Takita
collection DOAJ
description In the quest for the development of accurate, reliable, and cost-effective biosensing technology for early diagnostics of prostate cancer, we describe here an electrochemical biosensor combining a simple transducing method of differential pulse voltammetry (DPV) with an RNA-based aptamer labelled with a methylene blue redox group acting as a highly specific bioreceptor to the prostate cancer biomarker PCA3. A series of DPV measurements on screen-printed gold electrodes is functionalised with a redox-labelled aptamer in solutions (either buffer or synthetic urine) containing PCA3 in a wide range of concentrations from 0.1 picomolar (pM) to 10 nanomolar (nM). In these measurements, the current peak values correlate with the concentration of PCA3 and yield a low detection limit (LDL) of 0.1 pM. Furthermore, the binding kinetics study revealed the high affinity of the aptamer to the target PCA3 with the affinity constants K<sub>D</sub> of about 3.0 × 10<sup>−8</sup> molar. In addition, the AFM study showed the increase in the molecular layer roughness caused by the binding of PCA3, which is a large RNA molecular fragment.
first_indexed 2024-03-11T06:35:47Z
format Article
id doaj.art-55659d9332874d5db30ec30e1b04a0e9
institution Directory Open Access Journal
issn 2673-4117
language English
last_indexed 2024-03-11T06:35:47Z
publishDate 2023-01-01
publisher MDPI AG
record_format Article
series Eng
spelling doaj.art-55659d9332874d5db30ec30e1b04a0e92023-11-17T10:53:17ZengMDPI AGEng2673-41172023-01-014136737910.3390/eng4010022Enhanced Performance Electrochemical Biosensor for Detection of Prostate Cancer Biomarker PCA3 Using Specific AptamerSarra Takita0Alexei Nabok1Anna Lishchuk2Magdi H. Mussa3David Smith4Material and Engineering Research Institute (MERI), Sheffield Hallam University, Sheffield S1 1WB, UKMaterial and Engineering Research Institute (MERI), Sheffield Hallam University, Sheffield S1 1WB, UKDepartment of Chemistry, University of Sheffield, Brook Hill, Sheffield S3 7HF, UKMaterial and Engineering Research Institute (MERI), Sheffield Hallam University, Sheffield S1 1WB, UKBiomolecular Sciences Research Centre (BMRC), Sheffield Hallam University, Sheffield S1 1WB, UKIn the quest for the development of accurate, reliable, and cost-effective biosensing technology for early diagnostics of prostate cancer, we describe here an electrochemical biosensor combining a simple transducing method of differential pulse voltammetry (DPV) with an RNA-based aptamer labelled with a methylene blue redox group acting as a highly specific bioreceptor to the prostate cancer biomarker PCA3. A series of DPV measurements on screen-printed gold electrodes is functionalised with a redox-labelled aptamer in solutions (either buffer or synthetic urine) containing PCA3 in a wide range of concentrations from 0.1 picomolar (pM) to 10 nanomolar (nM). In these measurements, the current peak values correlate with the concentration of PCA3 and yield a low detection limit (LDL) of 0.1 pM. Furthermore, the binding kinetics study revealed the high affinity of the aptamer to the target PCA3 with the affinity constants K<sub>D</sub> of about 3.0 × 10<sup>−8</sup> molar. In addition, the AFM study showed the increase in the molecular layer roughness caused by the binding of PCA3, which is a large RNA molecular fragment.https://www.mdpi.com/2673-4117/4/1/22prostate cancerPCA3 biomarkeraptamerelectrochemical sensorsdigital pulse voltammetrybinding kinetics
spellingShingle Sarra Takita
Alexei Nabok
Anna Lishchuk
Magdi H. Mussa
David Smith
Enhanced Performance Electrochemical Biosensor for Detection of Prostate Cancer Biomarker PCA3 Using Specific Aptamer
Eng
prostate cancer
PCA3 biomarker
aptamer
electrochemical sensors
digital pulse voltammetry
binding kinetics
title Enhanced Performance Electrochemical Biosensor for Detection of Prostate Cancer Biomarker PCA3 Using Specific Aptamer
title_full Enhanced Performance Electrochemical Biosensor for Detection of Prostate Cancer Biomarker PCA3 Using Specific Aptamer
title_fullStr Enhanced Performance Electrochemical Biosensor for Detection of Prostate Cancer Biomarker PCA3 Using Specific Aptamer
title_full_unstemmed Enhanced Performance Electrochemical Biosensor for Detection of Prostate Cancer Biomarker PCA3 Using Specific Aptamer
title_short Enhanced Performance Electrochemical Biosensor for Detection of Prostate Cancer Biomarker PCA3 Using Specific Aptamer
title_sort enhanced performance electrochemical biosensor for detection of prostate cancer biomarker pca3 using specific aptamer
topic prostate cancer
PCA3 biomarker
aptamer
electrochemical sensors
digital pulse voltammetry
binding kinetics
url https://www.mdpi.com/2673-4117/4/1/22
work_keys_str_mv AT sarratakita enhancedperformanceelectrochemicalbiosensorfordetectionofprostatecancerbiomarkerpca3usingspecificaptamer
AT alexeinabok enhancedperformanceelectrochemicalbiosensorfordetectionofprostatecancerbiomarkerpca3usingspecificaptamer
AT annalishchuk enhancedperformanceelectrochemicalbiosensorfordetectionofprostatecancerbiomarkerpca3usingspecificaptamer
AT magdihmussa enhancedperformanceelectrochemicalbiosensorfordetectionofprostatecancerbiomarkerpca3usingspecificaptamer
AT davidsmith enhancedperformanceelectrochemicalbiosensorfordetectionofprostatecancerbiomarkerpca3usingspecificaptamer